RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Shailesh Singh to Tamoxifen

Back to Details
This is a "connection" page, showing publications Shailesh Singh has written about Tamoxifen.
Shailesh Singh
Connection Strength
0.227
Tamoxifen
  1. Singh S, Weindorfer C, Nandi A, Panneer Selvam C, Mendes G?tze M, Das M, Falaschini A, Tjendra Y, Boone MM, Dolznig H, Zhang Q, Clarke R, Thomas C, Chakrabarti R. DLL1-responsive PD-L1+ tumor-associated macrophages promote endocrine resistance in breast cancer. Sci Transl Med. 2025 Nov 05; 17(823):eadr6207.
    View in: PubMed
    Score: 0.227
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support